176 related articles for article (PubMed ID: 7682415)
1. 6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts.
Bökkerink JP; Stet EH; De Abreu RA; Damen FJ; Hulscher TW; Bakker MA; van Baal JA
Biochem Pharmacol; 1993 Apr; 45(7):1455-63. PubMed ID: 7682415
[TBL] [Abstract][Full Text] [Related]
2. Purine de novo synthesis as the basis of synergism of methotrexate and 6-mercaptopurine in human malignant lymphoblasts of different lineages.
Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RA; Schretlen ED
Biochem Pharmacol; 1988 Jun; 37(12):2321-7. PubMed ID: 2455519
[TBL] [Abstract][Full Text] [Related]
3. The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblasts.
Vogt MH; Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Trijbels FJ
Biochim Biophys Acta; 1993 Apr; 1181(2):189-94. PubMed ID: 7683208
[TBL] [Abstract][Full Text] [Related]
4. Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts.
Bökkerink JP; Bakker MA; Hulscher TW; De Abreu RR; Schretlen ED; van Laarhoven JP; De Bruyn CH
Biochem Pharmacol; 1986 Oct; 35(20):3549-55. PubMed ID: 2429667
[TBL] [Abstract][Full Text] [Related]
5. Dose-related effects of methotrexate on purine and pyrimidine nucleotides and on cell-kinetic parameters in MOLT-4 malignant human T-lymphoblasts.
Bökkerink JP; De Abreu RA; Bakker MA; Hulscher TW; Van Baal JM; De Vaan GA
Biochem Pharmacol; 1986 Oct; 35(20):3557-64. PubMed ID: 2429668
[TBL] [Abstract][Full Text] [Related]
6. Effects of methotrexate on purine and pyrimidine metabolism and cell-kinetic parameters in human malignant lymphoblasts of different lineages.
Bökkerink JP; De Abreu RA; Bakker MA; Hulscher TW; van Baal JM; Schretlen ED; De Bruijn CH
Biochem Pharmacol; 1988 Jun; 37(12):2329-38. PubMed ID: 2455520
[TBL] [Abstract][Full Text] [Related]
7. A biochemical basis for synergism of 6-mercaptopurine and mycophenolic acid in Molt F4, a human malignant T-lymphoblastic cell line.
Stet EH; De Abreu RA; Janssen YP; Bökkerink JP; Trijbels FJ
Biochim Biophys Acta; 1993 Jan; 1180(3):277-82. PubMed ID: 8422434
[TBL] [Abstract][Full Text] [Related]
8. Thiopurine induced disturbance of DNA methylation in human malignant cells.
De Abreu R; Lambooy L; Stet E; Vogels-Mentink T; Van den Heuvel L
Adv Enzyme Regul; 1995; 35():251-63. PubMed ID: 7572347
[TBL] [Abstract][Full Text] [Related]
9. Reversal of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside cytotoxicity by amidoimidazole carboxamide ribonucleoside in Molt F4 human malignant T-lymphoblasts.
Stet EH; De Abreu RA; Bökkerink JP; Vogels-Mentink TM; Lambooy LH; Trijbels FJ; Trueworthy RC
Biochem Pharmacol; 1993 Aug; 46(3):547-50. PubMed ID: 8347177
[TBL] [Abstract][Full Text] [Related]
10. Cell-kinetics and biochemical pharmacology of methotrexate and 6-mercaptopurine in human malignant T-lymphoblasts.
Bökkerink JP; De Abreu RA; Stet EH; Damen FJ
Klin Padiatr; 1992; 204(4):293-8. PubMed ID: 1518268
[TBL] [Abstract][Full Text] [Related]
11. On the biochemical modulation of 6-mercaptopurine by methotrexate in murine WEHI-3b leukemia cells in vitro.
Liliemark J; Pettersson B; Peterson C
Leuk Res; 1992; 16(3):275-80. PubMed ID: 1373210
[TBL] [Abstract][Full Text] [Related]
12. Decrease in S-adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblasts.
Stet EH; De Abreu RA; Bökkerink JP; Blom HJ; Lambooy LH; Vogels-Mentink TM; de Graaf-Hess AC; van Raay-Selten B; Trijbels FJ
Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):163-8. PubMed ID: 7998928
[TBL] [Abstract][Full Text] [Related]
13. [6-Mercaptopurine and methotrexate, rational use in sight after 35 years?].
Bökkerink JP; Schouten TJ; De Abreu RA; Lippens RJ; De Vaan GA; De Bruyn CH; Van Laarhoven JP
Tijdschr Kindergeneeskd; 1984 Aug; 52(4):118-23. PubMed ID: 6593896
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
Dayton JS; Turka LA; Thompson CB; Mitchell BS
Mol Pharmacol; 1992 Apr; 41(4):671-6. PubMed ID: 1569921
[TBL] [Abstract][Full Text] [Related]
15. Effects on transmethylation by high-dose 6-mercaptopurine and methotrexate infusions during consolidation treatment of acute lymphoblastic leukemia.
Keuzenkamp-Jansen CW; De Abreu RA; Blom HJ; Bökkerink JP; Trijbels JM
Biochem Pharmacol; 1996 May; 51(9):1165-71. PubMed ID: 8645339
[TBL] [Abstract][Full Text] [Related]
16. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
Wilson JM; Mitchell BS; Daddona PE; Kelley WN
J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
[TBL] [Abstract][Full Text] [Related]
17. Some biochemical characteristics of L1210 cell lines resistant to 6-mercaptopurine and 6-thioguanine and with increased sensitivity to methotrexate.
Strobel-Stevens JD; El Dareer SM; Trader MW; Hill DL
Biochem Pharmacol; 1982 Oct; 31(19):3133-7. PubMed ID: 6890814
[TBL] [Abstract][Full Text] [Related]
18. Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism.
Bo J; Schrøder H; Kristinsson J; Madsen B; Szumlanski C; Weinshilboum R; Andersen JB; Schmiegelow K
Cancer; 1999 Sep; 86(6):1080-6. PubMed ID: 10491537
[TBL] [Abstract][Full Text] [Related]
19. Early mitogenic stimulation of metabolic flux through phosphoribosyl pyrophosphate into nucleotides in Swiss 3T3 cells and requirement of external magnesium for the response.
Tatibana M; Ishijima S; Kita K; Ishizuka T; Suzuki N
Adv Enzyme Regul; 1989; 28():147-66. PubMed ID: 2483026
[TBL] [Abstract][Full Text] [Related]
20. Delayed cytotoxicity of 6-mercaptopurine is compatible with mitotic death caused by DNA damage due to incorporation of 6-thioguanine into DNA as 6-thioguanine nucleotide.
Inamochi H; Higashigawa M; Shimono Y; Nagata T; Cao DC; Mao XY; M'soka T; Hori H; Kawasaki H; Sakurai M
J Exp Clin Cancer Res; 1999 Sep; 18(3):417-24. PubMed ID: 10606189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
